Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Interferon-lambda: a new addition to an old family.

Donnelly RP, Kotenko SV.

J Interferon Cytokine Res. 2010 Aug;30(8):555-64. doi: 10.1089/jir.2010.0078. Review.

2.

Novel type III interferons produce anti-tumor effects through multiple functions.

Li Q, Kawamura K, Tada Y, Shimada H, Hiroshima K, Tagawa M.

Front Biosci (Landmark Ed). 2013 Jun 1;18:909-18. Review.

PMID:
23747856
3.

Interferons lambda, new cytokines with antiviral activity.

Lopušná K, Režuchová I, Betáková T, Skovranová L, Tomašková J, Lukáčiková L, Kabát P.

Acta Virol. 2013;57(2):171-9. Review.

PMID:
23600875
4.

Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.

Yu D, Zhao M, Dong L, Zhao L, Zou M, Sun H, Zhang M, Liu H, Zou Z.

Drug Des Devel Ther. 2016 Jan 6;10:163-82. doi: 10.2147/DDDT.S91455. eCollection 2016.

5.
6.

IFN-λs.

Kotenko SV.

Curr Opin Immunol. 2011 Oct;23(5):583-90. doi: 10.1016/j.coi.2011.07.007. Epub 2011 Aug 15. Review.

7.

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP.

Nat Immunol. 2003 Jan;4(1):69-77. Epub 2002 Dec 16.

PMID:
12483210
8.

Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection.

Stoltz M, Klingström J.

J Virol. 2010 Sep;84(18):9140-8. doi: 10.1128/JVI.00717-10. Epub 2010 Jun 30.

9.

Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses.

Li M, Liu X, Zhou Y, Su SB.

J Leukoc Biol. 2009 Jul;86(1):23-32. doi: 10.1189/jlb.1208761. Epub 2009 Apr 30. Review.

PMID:
19304895
10.

Interferon-λ in the context of viral infections: production, response and therapeutic implications.

Hermant P, Michiels T.

J Innate Immun. 2014;6(5):563-74. doi: 10.1159/000360084. Epub 2014 Apr 17. Review.

11.

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity.

Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR.

J Immunol. 2008 Feb 15;180(4):2474-85.

12.

Mechanisms of type III interferon expression.

Iversen MB, Paludan SR.

J Interferon Cytokine Res. 2010 Aug;30(8):573-8. doi: 10.1089/jir.2010.0063. Review.

PMID:
20645874
13.

Parainfluenza Virus 3 Blocks Antiviral Mediators Downstream of the Interferon Lambda Receptor by Modulating Stat1 Phosphorylation.

Eberle KC, McGill JL, Reinhardt TA, Sacco RE.

J Virol. 2015 Dec 30;90(6):2948-58. doi: 10.1128/JVI.02502-15.

14.

What have we learned from the IL28 receptor knockout mouse?

Mordstein M, Michiels T, Staeheli P.

J Interferon Cytokine Res. 2010 Aug;30(8):579-84. doi: 10.1089/jir.2010.0061. Review.

PMID:
20649452
15.

Viral infections activate types I and III interferon genes through a common mechanism.

Onoguchi K, Yoneyama M, Takemura A, Akira S, Taniguchi T, Namiki H, Fujita T.

J Biol Chem. 2007 Mar 9;282(10):7576-81. Epub 2007 Jan 4.

16.

Antiviral activity of type I and type III interferons against porcine reproductive and respiratory syndrome virus (PRRSV).

Luo R, Fang L, Jin H, Jiang Y, Wang D, Chen H, Xiao S.

Antiviral Res. 2011 Aug;91(2):99-101. doi: 10.1016/j.antiviral.2011.04.017. Epub 2011 May 4.

PMID:
21569798
17.

Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets.

Lind K, Richardson SJ, Leete P, Morgan NG, Korsgren O, Flodström-Tullberg M.

J Virol. 2013 Jul;87(13):7646-54. doi: 10.1128/JVI.03431-12. Epub 2013 May 1.

18.

Biological activity of interleukins-28 and -29: comparison with type I interferons.

Meager A, Visvalingam K, Dilger P, Bryan D, Wadhwa M.

Cytokine. 2005 Jul 21;31(2):109-18.

PMID:
15899585
19.

Potential anti-tumor effect of IFN-λ2 (IL-28A) against human lung cancer cells.

Tezuka Y, Endo S, Matsui A, Sato A, Saito K, Semba K, Takahashi M, Murakami T.

Lung Cancer. 2012 Dec;78(3):185-92. doi: 10.1016/j.lungcan.2012.09.005. Epub 2012 Sep 27.

PMID:
23021208
20.

Antiviral effect of interferon lambda against West Nile virus.

Ma D, Jiang D, Qing M, Weidner JM, Qu X, Guo H, Chang J, Gu B, Shi PY, Block TM, Guo JT.

Antiviral Res. 2009 Jul;83(1):53-60. doi: 10.1016/j.antiviral.2009.03.006. Epub 2009 Apr 1.

Supplemental Content

Support Center